本文通过对国内外医药生物技术产业现状的分析，详细阐述了中国生物制药企业目前所面临的机遇和挑战。
The paper analyzed the present developments in medical biotechnology industries home and abroad, and discussed the opportunities and challenges facing biopharmaceutical companies in China.
根据合作协议，应求苏州和凯杰苏州将共同加快生物标志物的发现及应用转化，从而更好的为中国生物制药市场提供服务。
Pursuant to the agreement, InvitroCue Suzhou and QIAGEN Suzhou will jointly accelerate the discovery of biomarkers and translational medicine research for the Chinese biopharmaceutical market.
诺和诺德是首家在中国设立研发中心的跨国生物制药公司。
Novo Nordisk was the first global pharmaceutical company to establish a research center in China.
诺和诺德是首家在中国设立研发中心的跨国生物制药公司。
Novo Nordisk was the first global pharmaceutical company to establish a research center in China.
应用推荐